Royal Bank of Canada
HZNP

Royal Bank of Canada’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Royal Bank of Canada’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,155
Closed -$3.14M – 7922
2023
Q3 		$3.14M Sell
27,155
-15,181
-36% -$1.63M ﹤0.01% 2469
2023
Q2 		$4.35M Sell
42,336
-212,936
-83% -$22.5M ﹤0.01% 2200
2023
Q1 		$27.9M Buy
255,272
+150,536
+144% +$16.6M 0.01% 938
2022
Q4 		$11.9M Sell
104,736
-42,919
-29% -$3.56M ﹤0.01% 1480
2022
Q3 		$9.14M Buy
147,655
+34,024
+30% +$2.38M ﹤0.01% 1606
2022
Q2 		$9.06M Sell
113,631
-75,806
-40% -$7.18M ﹤0.01% 1634
2022
Q1 		$19.9M Buy
189,437
+63,397
+50% +$6.18M 0.01% 1240
2021
Q4 		$13.6M Buy
126,040
+9,406
+8% +$1.03M ﹤0.01% 1676
2021
Q3 		$12.8M Buy
116,634
+7,460
+7% +$774K ﹤0.01% 1652
2021
Q2 		$10.2M Buy
109,174
+11,874
+12% +$1.09M ﹤0.01% 1809
2021
Q1 		$8.96M Buy
97,300
+51,152
+111% +$4.32M ﹤0.01% 1830
2020
Q4 		$3.38M Buy
46,148
+14,378
+45% +$1.07M ﹤0.01% 2476
2020
Q3 		$2.47M Buy
31,770
+5,651
+22% +$389K ﹤0.01% 2511
2020
Q2 		$1.45M Buy
26,119
+12,978
+99% +$555K ﹤0.01% 2871
2020
Q1 		$389K Sell
13,141
-2,059
-14% -$69.7K ﹤0.01% 3833
2019
Q4 		$550K Buy
15,200
+3,234
+27% +$99.2K ﹤0.01% 3917
2019
Q3 		$325K Sell
11,966
-4,524
-27% -$117K ﹤0.01% 4125
2019
Q2 		$397K Sell
16,490
-12,106
-42% -$307K ﹤0.01% 4003
2019
Q1 		$756K Buy
28,596
+24,934
+681% +$591K ﹤0.01% 3423
2018
Q4 		$72K Sell
3,662
-19,160
-84% -$376K ﹤0.01% 4912
2018
Q3 		$447K Buy
22,822
+22,190
+3,511% +$422K ﹤0.01% 3970
2018
Q2 		$10K Sell
632
-168
-21% -$2.56K ﹤0.01% 5839
2018
Q1 		$11K Sell
800
-380
-32% -$5.61K ﹤0.01% 5697
2017
Q4 		$17K Sell
1,180
-12,053
-91% -$169K ﹤0.01% 5673
2017
Q3 		$168K Buy
13,233
+11,804
+826% +$150K ﹤0.01% 4641
2017
Q2 		$17K Sell
1,429
-896,685
-100% -$11.2M ﹤0.01% 5609
2017
Q1 		$13.3M Buy
898,114
+240,783
+37% +$3.9M 0.01% 1310
2016
Q4 		$10.6M Buy
657,331
+612,032
+1,351% +$11.1M 0.01% 1466
2016
Q3 		$821K Buy
45,299
+19,224
+74% +$376K ﹤0.01% 3273
2016
Q2 		$429K Buy
26,075
+7,070
+37% +$114K ﹤0.01% 3826
2016
Q1 		$316K Sell
19,005
-20,015
-51% -$350K ﹤0.01% 4026
2015
Q4 		$845K Buy
39,020
+18,887
+94% +$368K ﹤0.01% 3266
2015
Q3 		$399K Buy
20,133
+2,051
+11% +$64.8K ﹤0.01% 3735
2015
Q2 		$629K Buy
18,082
+18,081
+1,808,100% +$552K ﹤0.01% 3385
2015
Q1 		$0 Buy
+1
New +$18 ﹤0.01% 6549
2014
Q4 		– Sell
-147,613
Closed -$1.81M – 6391
2014
Q3 		$1.81M Buy
147,613
+49,000
+50% +$569K ﹤0.01% 2390
2014
Q2 		$1.56M Buy
+98,613
New +$1.41M ﹤0.01% 2483
2014
Q1 		– Sell
-128,000
Closed -$975K – 6258
2013
Q4 		$975K Buy
128,000
+127,723
+46,109% +$689K ﹤0.01% 2855
2013
Q3 		$1K Buy
+277
New +$730 ﹤0.01% 5991

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's HZNP Position: Q4 2023 in Review

Royal Bank of Canada sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 27,155 shares — an estimated $3.14M sold.

Royal Bank of Canada first reported a position in HZNP in Q3 2013 and held it in 39 quarters. The position peaked at $27.9M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Royal Bank of Canada reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 27,155 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $3.14M.
  • Royal Bank of Canada first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 39 quarters.
  • Royal Bank of Canada's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $27.9M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.